GGI
MRK icon

Godsey & Gibb Inc’s Merck MRK Stock Holding History

Godsey & Gibb Inc’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9M Sell
224,875
-4,545
-2% -$532K 2.37% 11
2026
Q1 		$27.6M Sell
229,420
-925
-0.4% -$107K 2.4% 13
2025
Q4 		$24.2M Buy
230,345
+3,258
+1% +$306K 2.18% 18
2025
Q3 		$19.1M Buy
227,087
+12,168
+6% +$1M 1.68% 35
2025
Q2 		$17M Buy
214,919
+6,790
+3% +$540K 1.59% 38
2025
Q1 		$18.7M Buy
208,129
+22,125
+12% +$2.07M 1.84% 36
2024
Q4 		$18.5M Buy
186,004
+9,571
+5% +$987K 1.85% 31
2024
Q3 		$20M Buy
176,433
+3,198
+2% +$380K 1.92% 31
2024
Q2 		$21.4M Sell
173,235
-19,144
-10% -$2.47M 2.22% 13
2024
Q1 		$25.4M Sell
192,379
-1,003
-0.5% -$124K 2.67% 8
2023
Q4 		$21.1M Buy
193,382
+2,049
+1% +$213K 2.39% 11
2023
Q3 		$19.7M Sell
191,333
-2,406
-1% -$259K 2.42% 12
2023
Q2 		$22.4M Sell
193,739
-12,118
-6% -$1.38M 2.54% 6
2023
Q1 		$21.9M Sell
205,857
-8,149
-4% -$880K 2.57% 7
2022
Q4 		$23.7M Buy
+214,006
New +$21.9M 4.5% 2
2022
Q2 		– Sell
-229,236
Closed -$18.8M – 147
2022
Q1 		$18.8M Buy
+229,236
New +$18.1M 7.15% 7
2021
Q2 		– Sell
-220,732
Closed -$16.2M – 137
2021
Q1 		$16.2M Buy
220,732
+14,561
+7% +$1.07M 2% 31
2020
Q4 		$16.1M Buy
206,171
+10,073
+5% +$770K 2.17% 26
2020
Q3 		$15.5M Buy
196,098
+617
+0.3% +$48.3K 2.34% 17
2020
Q2 		$14.4M Sell
195,481
-71
-0% -$5.34K 2.31% 16
2020
Q1 		$14.4M Sell
195,552
-1,734
-0.9% -$136K 2.73% 7
2019
Q4 		$17.1M Buy
197,286
+2,991
+2% +$246K 2.4% 15
2019
Q3 		$15.6M Sell
194,295
-21,442
-10% -$1.72M 2.38% 26
2019
Q2 		$17.3M Sell
215,737
-575
-0.3% -$44K 2.49% 12
2019
Q1 		$17.2M Sell
216,312
-1,686
-0.8% -$126K 2.61% 10
2018
Q4 		$15.9M Buy
217,998
+854
+0.4% +$60.3K 2.86% 6
2018
Q3 		$14.7M Buy
217,144
+9,065
+4% +$578K 2.35% 15
2018
Q2 		$12.1M Sell
208,079
-21,870
-10% -$1.23M 2.08% 25
2018
Q1 		$12M Buy
229,949
+12,366
+6% +$668K 2.11% 31
2017
Q4 		$11.7M Sell
217,583
-920
-0.4% -$51K 1.97% 38
2017
Q3 		$13.3M Sell
218,503
-15,413
-7% -$934K 2.28% 26
2017
Q2 		$14.3M Buy
233,916
+9,957
+4% +$606K 2.51% 17
2017
Q1 		$13.6M Sell
223,959
-9,856
-4% -$598K 2.47% 22
2016
Q4 		$13.1M Sell
233,815
-1,021
-0.4% -$59.8K 2.44% 23
2016
Q3 		$14M Buy
234,836
+1,572
+0.7% +$91.9K 2.5% 14
2016
Q2 		$12.8M Buy
233,264
+2,121
+0.9% +$113K 2.33% 19
2016
Q1 		$11.7M Buy
231,143
+2,716
+1% +$133K 2.25% 25
2015
Q4 		$11.5M Buy
228,427
+3,509
+2% +$177K 2.27% 24
2015
Q3 		$10.6M Sell
224,918
-3,149
-1% -$167K 2.18% 28
2015
Q2 		$12.4M Buy
228,067
+2,499
+1% +$140K 2.2% 20
2015
Q1 		$12.4M Buy
225,568
+15,639
+7% +$886K 2.22% 20
2014
Q4 		$11.4M Buy
209,929
+5,201
+3% +$290K 2.12% 30
2014
Q3 		$11.6M Buy
204,728
+13,136
+7% +$738K 2.18% 21
2014
Q2 		$10.6M Buy
191,592
+40,421
+27% +$2.21M 2% 31
2014
Q1 		$8.19M Buy
151,171
+11,921
+9% +$617K 1.65% 40
2013
Q4 		$6.65M Buy
139,250
+26,450
+23% +$1.21M 1.35% 45
2013
Q3 		$5.12M Buy
112,800
+17,826
+19% +$814K 1.13% 45
2013
Q2 		$4.21M Buy
+94,974
New +$4.24M 0.97% 48

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Godsey & Gibb Inc's MRK Position: Q2 2026 in Review

Godsey & Gibb Inc reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $532K and leaving 224,875 shares worth $28.9M. The position accounts for 2.37% of the portfolio, ranked #11.

Godsey & Gibb Inc first reported a position in MRK in Q2 2013 and has held it in 48 quarters since. 814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Godsey & Gibb Inc held 224,875 shares of Merck worth $28.9M as of Q2 2026.
  • Godsey & Gibb Inc sold 4,545 Merck shares in Q2 2026, an estimated $532K.
  • Merck made up 2.37% of Godsey & Gibb Inc's portfolio in Q2 2026, its #11 holding.
  • Godsey & Gibb Inc first reported a position in Merck in Q2 2013 and has held it in 48 quarters since.
  • 814 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.